SHOCK - THD Internal Medicine Training Program
Download
Report
Transcript SHOCK - THD Internal Medicine Training Program
Pathyophysiology and
Classification of Shock
KENNEY WEINMEISTER M.D.
Definition
Shock is a physiologic state characterized
by a significant, systemic reduction in tissue
perfusion, thereby resulting in decreased
tissue oxygen delivery.
Stages of Shock
Early, Preshock, Warm shock
Compensation by body’s homeostatic
mechanisms
• Tachycardia, Peripheral vasodilatation and
modest decrement in systemic BP
Stages of Shock
Shock
Homeostatic mechanisms are overwhelmed
Signs and symptoms of organ dysfunction
• Tachycardia, tachypnea, metabolic acidosis,
oliguria, and cool and clammy skin
• 20 to 25% fall in effective blood volume
• Fall in CI to < 2.5L/min/M2
• Activation of mediators of sepsis
Stages of Shock
End Organ Dysfunction
Pathophysiology
•
•
•
•
AG II & NE cause increased Ca+2 in cytosol
Ca + calmodulin = P+myosin
P+myosin + actin = Myosin ATPase
Myosin ATPase = muscle contraction
Pathophysiology of End Organ
Shock
Activation of ATP sensitive potassium
channels
• Activation causes hyperpolarization
• Closure of Ca channels
• Activated by decrease in cellular ATP and
increases in cellular H+ and lactate
• Natriuretic peptide and nitric oxide
Pathophysiology of End Organ
Shock
Increased production on Nitric Oxide
• activation of myosin light-chain phosphatase
• leads to dephosphoralation of myosin
Vasopressin deficiency
•
•
•
•
potentiates vasoconstrictor effects of NE
directly inactivates Katp channels
blunts increase in cGMP
decreases synthesis of NO synthase
Pathophysiology of End Organ
Shock
Vascular smooth muscle tone is lost
Resistant vasodilatation
End organ dysfunction and death
Classification of Shock
Hypovolemic shock
Cardiogenic shock
Distributive shock
Hypovolemic Shock
Results from decreased preload
Hemorrhagic
• Trauma, GIB, Ruptured aneurysm
Volume loss
• Third spacing, GI losses, burns, insensible
losses
Cardiogenic Shock
Pump failure
Cardiomyopathies
• Ischemic right and left ventricle,
• Dilated
• Stunned myocardium
Cardiogenic Shock continued
Arrhythmia's
• Bradyarrhythmias
• Tachyarrhythmias
Mechanical
• Valvular; MR, AI, AS
• VSD
• Atrial myxoma
Cardiogenic Shock continued
Obstructive
•
•
•
•
•
Massive PE
Tension pneumothorax
Constrictive pericarditis
Tamponade
Severe pulmonary hypertension
Distributive Shock
Vasodilatory shock resulting in severe
decrease in SVR
•
•
•
•
•
Septic shock
Activation of systemic inflammatory response
Toxic shock syndrome
Anaphylaxis
Drug or toxins
Distributive Shock continued
Addisonian crisis
Myxedema coma
Neurogenic shock
Evaluation
H&P
Labs
CXR
EKG
Treatment
Goal is early intervention to prevent
irreversible organ damage
• Recognize early shock
• Diagnose and correct the underlying cause
Early goal directed therapy in sepsis
• In hospital mortality 46.5% vs 30.5% for
treatment group
• NEJM, vol 345,No 19 Nov 8 2001
Treatment
Fluid resuscitation
• CVP 8-12
Vasopressors
•
•
•
•
Norepinephrin infuse mcg/min (4mcg/min)
Dopamine infuse mcg/kg/min
Epinephrine infuse mcg/min (range 1-10 mcg)
Vasopressin infuse units/min (range 0.01 to 0.1
units/minute)
No bubble is so iridescent or
floats longer than that blown by
the successful teacher.
Sir William Osler